Novel theranostic approach for radioimmunotherapy achieves curative responses in colorectal cancer tumors

MedicalXpress | avr. 30, 2026

A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a preclinical colorectal cancer model. The multi-step theranostic approach delivers alpha-emitting radiation directly to tumors while limiting exposure to healthy tissues. This research is published in the May issue of The Journal of Nuclear Medicine.